nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—UGT2B15—gall bladder—sclerosing cholangitis	0.441	0.441	CbGeAlD
Lorazepam—UGT2B15—pancreas—sclerosing cholangitis	0.203	0.203	CbGeAlD
Lorazepam—UGT2B15—liver—sclerosing cholangitis	0.129	0.129	CbGeAlD
Lorazepam—TSPO—pancreas—sclerosing cholangitis	0.0727	0.0727	CbGeAlD
Lorazepam—GABRB3—pancreas—sclerosing cholangitis	0.066	0.066	CbGeAlD
Lorazepam—TSPO—liver—sclerosing cholangitis	0.0463	0.0463	CbGeAlD
Lorazepam—GABRB3—liver—sclerosing cholangitis	0.042	0.042	CbGeAlD
